Glycotest
Glycotest is developing blood tests for the large populations at risk of developing liver cancers and fibrosis-cirrhosis.
Based based in Greater New York Area, East Coast, Northeastern US, Glycotest works in biotechnology, health care, pharmaceutical, founded in 2012.
Within the biotechnology, health care, pharmaceutical space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in Greater New York Area, East Coast, Northeastern US.
Its current recorded stage is Series_A.
The company reports a headcount in the c_00001_00010 range.
It has disclosed roughly $10M in funding.
| Sector | Biotechnology, Health Care, Pharmaceutical |
|---|---|
| Headquarters | Greater New York Area, East Coast, Northeastern US |
| Founded | 2012 |
| Employees | c_00001_00010 |
| Stage | series_a |
| Total funding | $10,000,000 |
Website: glycotest.com
Sign in to view the contact information we hold for Glycotest.
Create a free account
Create a free account